Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression

Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther. 2010;12:206–14.

Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388:2039–52.

Ramonda R, Oliviero F, Galozzi P, Frallonardo P, Ortolan A, et al. Molecular mechanisms of pain in crystal-induced arthritis. Best Pract Res Clin Rheumatol. 2015;29:98–110.

Rees F, Hui M, Doherty M. Optimizing current treatment of gout. Nat Rev Rheumatol. 2014;10:271–83.

Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41.

Martin WJ, Walton M, Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum. 2009;60:281–9.

Trevisan G, Hoffmeister C, Rossato MF, Oliveira SM, Silva MA, Silva CR, et al. TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout. Free Radic Biol Med. 2014;72:200–9.

Ren K, Torres R. Role of interleukin-1β during pain and inflammation. Brain Res Rev. 2009;60:57–64.

Pope RM, Tschopp J. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum. 2007;56:3183–8.

Torres R, Macdonald L, Croll SD, Reinhardt J, Dore A, Silva CR, et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis. 2009;68:1602–8.

Reber LL, Marichal T, Sokolove J, Starkl P, Gaudenzio N, Iwakura Y, et al. Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice. Arthritis Rheumatol. 2014;66:2881–91.

Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest. 2006;116:2262–71.

Walsh JG, Muruve DA, C P. Inflammasomes in the CNS. Nat Rev Neurosci. 2014;15:84–97.

Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13:397–411.

Amaral FA, Costa VV, Tavares LD, Sachs D, Coelho FM, Fagundes CT, et al. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout. Arthritis Rheum. 2012;64:474–84.

Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi HK. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum. 2012;64:4004–11.

Usenik V, Fajt N, Mikulic-Petkovsek M, Slatnar A, Stampar F, Veberic R. Sweet cherry pomological and biochemical characteristics influenced by rootstock. J Agric Food Chem. 2010;58:4928–33.

Martinez-Micaelo N, González-Abuín N, Pinent M, Ardévol A, Blay M. Procyanidin B2 inhibits inflammasome-mediated IL-1β production in lipopolysaccharide-stimulated macrophages. Mol Nutr Food Res. 2015;59:262–9.

Williams R, Spencer JPE, Riceevans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. 2004;36:838–49.

Cai Y, Kong H, Pan YB, Jiang L, Pan XX, Hu L, et al. Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microglia. J Neuroinflammation. 2016;13:53–67.

Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63.

Hoffmeister C, Silva MA, Rossato MF, Trevisan G, Oliveira SM, Guerra GP, et al. Participation of the TRPV1 receptor in the development of acute gout attacks. Rheumatology. 2014;53:240–9.

Sanjai K, Kumarswamy J, Patil A, Papaiah L, Jayaram S, Krishnan L. Evaluation and comparison of decalcification agents on the human teeth. J Oral Maxillofac Pathol. 2012;16:222–7.

Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol. 2010;40:616–9.

Jin C, Flavell RA. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol. 2010;30:628–31.

Dinarello CA. How interleukin-1β induces gouty arthritis. Arthritis Rheum. 2010;62:3140–4.

Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, et al. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci. 2003;23:8692–700.

Khanna PP, Gladue HS, Singh MK, FitzGerald JD, Bae S, Prakash S, et al. Treatment of acute gout: a systematic review. Semin Arthritis Rheum. 2014;44:31–8.

Hoffmeister C, Trevisan G, Rossato MF, de Oliveira SM, Gomez MV, Ferreira J. Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats. Pain. 2011;152:1777–88.

Sanz M, Cadahía E, Esteruelas E, Muñoz AM, Fernández De Simón B, Hernández T, et al. Phenolic compounds in cherry (Prunus avium) heartwood with a view to their use in cooperage. J Agric Food Chem. 2010;58:4907–14.

Yilmaz Y, Toledo RT. Health aspects of functional grape seed constituents. Trends Food Sci Technol. 2004;15:422–33.

Amaral FA, Bastos LF, Oliveira TH, Dias AC, Oliveira VL, Tavares LD, et al. Transmembrane TNF-α is sufficient for articular inflammation and hypernociception in a mouse model of gout. Eur J Immunol. 2016;46:204–11.

Zhu F, Yin L, Ji L, Yang F, Zhang G, Shi L, et al. Suppressive effect of Sanmiao formula on experimental gouty arthritis by inhibiting cartilage matrix degradation: an in vivo and in vitro study. Int Immunopharmacol. 2016;30:36–42.

Kingsbury SR, Conaghan, McDermott MF. The role of the NLRP3 inflammasome in gout. J Inflamm Re. 2011;4:39–49.

Haneklaus M, Oneill LA, Coll RC. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Curr Opin Immunol. 2013;25:40–5.

Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2015;13:148–59.

Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ, Qiu JH, et al. Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes. J Inflamm. 2015;12:30–8.

Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11:136–40.

Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC, Salter RD. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol. 2013;191:5230–8.

Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2010;469:221–5.

Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895–926.

Menétrey D, Gannon A, Levine JD, Basbaum AI. Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol. 1989;285:177–95.

Sweitzer SM, Peters MC, Ma JY, Kerr I, Mangadu R, Chakravarty S, et al. Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia. Pain. 2004;111:278–85.

Baldassare JJ, Bi Y, Bellone CJ. The role of p38 mitogen-activated protein kinase in IL-1β transcription. J Immunol. 1999;162:5367–73.